Evolving Role of BTK Inhibitors in CLL: Sequencing, Combinations, and Novel Agents

Gain insights on the evolving role of BTK inhibitors for patients with CLL with an on-demand webcast downloadable slidesets and a podcast on frequently asked questions in CLL.

Share

Program Content

Activities

BTKi in CLL
Evolving Role of BTK Inhibitors in CLL: Sequencing, Combinations, and Novel Agents
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 05, 2022

Expires: October 04, 2023

EP: BTKi for CLL
ExpressPoints:
Evolving Role of BTK Inhibitors in CLL: Sequencing, Combinations, and Novel Agents
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 10, 2022

Expires: October 09, 2023

No activities added yet

Activities

BTKi Role in CLL
Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2022

Expires: November 08, 2023

Provided by

ProCE Banner

Supporters

This CE activity is supported through an educational grant from

AstraZeneca

BeiGene

Lilly